Jagadeesh Babu Rangisetty
About Jagadeesh Babu Rangisetty
Data last updated:
Jagadeesh Babu Rangisetty is a Managing Director at Biophore India Pharmaceuticals Private Limited (since 2007), Director at Sionc Pharmaceuticals Private Limited (since 2008) and Director at Azico Biophore India Private Limited (since 2015), and holds 8 more current directorships. The companies operate in Pharma, Biotechnology and Agriculture. The 8 current companies with reported revenue have a combined latest revenue of ₹959 Cr; the largest is Biophore India Pharmaceuticals Private Limited at ₹457 Cr (FY 2025). Earlier, Jagadeesh Babu Rangisetty was a Director at Leiutis Pharmaceuticals Private Limited (2012–2021) and Individual Promoter at Goldmargh Venture Capital Private Limited (2018–2019) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biophore India Pharmaceuticals Private Limited U24232TG2007PTC053381 | Managing Director | 29 Mar 2007 | 2007 | ₹457 Cr (FY 2025) | Active |
 Sionc Pharmaceuticals Private Limited U24232AP2008PTC057417 | Director | 01 Feb 2008 | 2008 | ₹148 Cr (FY 2024) | Active |
 Azico Biophore India Private Limited U24233TG2008PTC061809 | Director | 11 May 2015 | 2008 | ₹140 Cr (FY 2024) | Active |
| Zenara Pharma Private Limited U24239TG2004PTC042894 | Director | 21 Jan 2017 | 2004 | ₹85.73 Cr (FY 2025) | Active |
 Leiutis Pharmaceuticals Llp AAX-0501 | Designated Partner | 17 May 2021 | 2021 | ₹52.13 Cr (FY 2025) | Active |
 Vivere Imaging Private Limited U24230TG2020PTC139316 | Director | 18 Feb 2020 | 2020 | ₹45.31 Cr (FY 2025) | Active |
| Teadus Pharma Private Limited U24230TG2023PTC170281 | Managing Director | 12 Mar 2025 | 2023 | ₹18.70 Cr (FY 2024) | Active |
| Alithia Pharmaceuticals Private Limited U24290TG2021PTC152799 | Director | 05 Jul 2021 | 2021 | ₹12.08 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Leiutis Pharmaceuticals Private Limited U73100AP2012PTC078351 | Director | 10 Sep 2012 | 2012 | ₹16.75 Cr (FY 2020) | Converted To Llp |
| Goldmargh Venture Capital Private Limited U65924TG2018PTC122241 | Individual Promoter | 13 Feb 2018 | 2018 | Converted To Llp | |
 Zystus Nutraceuticals Private Limited U73100TG2018PTC127825 | Director | 23 Oct 2018 | 2018 | ₹30.6 Lakh (FY 2022) | Active |
 Enixta Innovations Private Limited U72200TG2014PTC094559 | Director | 20 Jun 2014 | 2014 | ₹76.1 Lakh (FY 2024) | Strike Off |
| Sahaj Life Sciences India Private Limited U01407TG2008PTC060210 | Director | 18 Jul 2008 | 2008 | Strike Off | |
| Goldmargh Venture Capital Llp AAO-5861 | Designated Partner | 19 Mar 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jagadeesh Babu Rangisetty
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagadeesh Babu Rangisetty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagadeesh Babu Rangisetty
Jagadeesh Babu Rangisetty currently holds 11 directorships: Biophore India Pharmaceuticals Private Limited (Managing Director, since 29 Mar 2007, revenue ₹457 Cr (FY 2025)); Sionc Pharmaceuticals Private Limited (Director, since 01 Feb 2008, revenue ₹148 Cr (FY 2024)); Azico Biophore India Private Limited (Director, since 11 May 2015, revenue ₹140 Cr (FY 2024)); Zenara Pharma Private Limited (Director, since 21 Jan 2017, revenue ₹85.73 Cr (FY 2025)); Leiutis Pharmaceuticals Llp (Designated Partner, since 17 May 2021, revenue ₹52.13 Cr (FY 2025)); and 6 more.
Jagadeesh Babu Rangisetty was first appointed on 29 Mar 2007 as Managing Director at Biophore India Pharmaceuticals Private Limited. The most recent appointment on record is 06 Jul 2026 at Ewings Ventures Llp.
The 8 current companies of Jagadeesh Babu Rangisetty that report revenue have a combined latest revenue of ₹959 Cr: Biophore India Pharmaceuticals Private Limited ₹457 Cr (FY 2025); Sionc Pharmaceuticals Private Limited ₹148 Cr (FY 2024); Azico Biophore India Private Limited ₹140 Cr (FY 2024); Zenara Pharma Private Limited ₹85.73 Cr (FY 2025); Leiutis Pharmaceuticals Llp ₹52.13 Cr (FY 2025); and 3 more.
Jagadeesh Babu Rangisetty held 6 earlier board appointments: Leiutis Pharmaceuticals Private Limited (Director, 10 Sep 2012 to 16 May 2021); Goldmargh Venture Capital Private Limited (Individual Promoter, 13 Feb 2018 to 18 Mar 2019); Zystus Nutraceuticals Private Limited (Director, 23 Oct 2018 to 15 Feb 2021); Enixta Innovations Private Limited (Director, 20 Jun 2014 to 06 Mar 2021); Sahaj Life Sciences India Private Limited (Director, from 18 Jul 2008); and 1 more.
The current boards of Jagadeesh Babu Rangisetty's companies include Harcharan Singh (Biophore India Pharmaceuticals Private Limited), Madhusudana Rao Kothapalli (Biophore India Pharmaceuticals Private Limited), Manikreddy Pullagurla (Biophore India Pharmaceuticals Private Limited), Baburao Dandamudi (Sionc Pharmaceuticals Private Limited), Srikanth Dandamudi (Sionc Pharmaceuticals Private Limited), Subba Rao Jetti (Sionc Pharmaceuticals Private Limited), among others.